Diagnostic utility of circulating plasma microRNA-101a in severity of coronary heart disease

ConclusionsCirculating miR-101a may be considered as a novel biomarker for evaluating the presence and severity of CHD.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research